<DOC>
	<DOC>NCT00130078</DOC>
	<brief_summary>Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.</brief_summary>
	<brief_title>Trial of SAVVY Vaginal Gel and HIV in Nigeria</brief_title>
	<detailed_description>Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 multi-center, fully-masked, randomized, placebo controlled trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>18 to 35 year old women HIV negative More than one sexual partner in past 3 months Average 3 coital acts per week Willing to use vaginal gel and condoms for 12 months HIV positive Pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>HIV Seronegativity</keyword>
	<keyword>HIV transmission</keyword>
</DOC>